Rare diseases
Investigational molecules
Locations
Back to France3 332 clinical trials in Corbeil Essonnes, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Filgotinib for Children and Teens with Juvenile Idiopathic Arthritis
FranceStudy of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma
FranceStudy Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer
FranceStudy on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy
FranceStudy of BMS-986288 and Nivolumab for Patients with Advanced Solid Tumors
FranceStudy on Lorlatinib for Patients with ALK-Positive or ROS1-Positive Non-Small Cell Lung Cancer Continuing from Previous Studies
FranceStudy on SENS-501 for Children with Severe Hearing Loss Due to Otoferlin Gene Mutations
FranceStudy of BMS-986158 Alone and with Ruxolitinib or Fedratinib for Patients with Intermediate or High Risk Myelofibrosis
FranceStudy on Immunosuppressive Therapies with Asfotase Alfa for Patients with Hypophosphatasia Experiencing Reduced Treatment Effectiveness
FranceStudy on How Larotrectinib Works in Adults with Solid Tumors with NTRK Gene Fusion
FranceStudy of Pembrolizumab, Favezelimab, and Lenvatinib for Patients with Renal Cell Carcinoma
FranceStudy Comparing Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in Adults New to Antiretroviral Therapy
FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on novel treatments for Type 1 and Type 2 Diabetes, particularly investigating therapies like tirzepatide for glycemic control and cardiovascular outcomes in patients with obesity and diabetes.
Groundbreaking trials in Multiple Myeloma treatment, evaluating combinations of targeted therapies including elranatamab, lenalidomide, and daratumumab for newly diagnosed and relapsed cases.
Research examining innovative treatments for Immune Thrombocytopenia, Polymyalgia Rheumatica, and Lupus Nephritis, focusing on targeted therapies and steroid-sparing approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
